Citations

Mayo Clinic

Showing 10 of 108523 citations.

An Anatomic and Kinematic Analysis of a New Total Wrist Arthroplasty Design
Hooke, Alexander W. , Pettersson, Kurt, Sagerfors, Marcus , An, Kai‐Nan, Rizzo, Marco , Sagerfors, Marcus

Journal of Wrist Surgery | April 23, 2015 | Volume: 04 | Issue: 02 | Pages: 121-127

10.1055/s-0035-1549288 | PMID 25945297 Get It

The Genetic Basis of Peripheral Arterial Disease
Kullo, Iftikhar J. , Leeper, Nicholas J.

Circulation Research | April 23, 2015 | Volume: 116 | Issue: 9 | Pages: 1551-1560

10.1161/circresaha.116.303518 | PMID 25908728 Get It

Several risk factors for atherosclerotic peripheral arterial disease (PAD), such as dyslipidemia, diabetes mellitus, and hypertension, are heritable. However, predisposition to PAD may be influenced by genetic variants acting independently of these risk factors. Identification of such genetic variants will provide insights into underlying pathophysiologic mechanisms and facilitate the development of novel diagnostic and therapeutic approaches. In contrast to coronary heart disease, relatively few genetic variants that influence susceptibility to PAD have been discovered. This may be, in part, because of greater clinical and genetic heterogeneity in PAD. In this review, we (1) provide an update on the current state of knowledge about the genetic basis of PAD, including results of family studies and candidate gene, linkage as well as genome-wide association studies; (2) highlight the challenges in investigating the genetic basis of PAD and possible strategies to overcome these challenges; and (3) discuss the potential of genome sequencing, RNA sequencing, differential gene expression, epigenetic profiling, and systems biology in increasing our understanding of the molecular genetics of PAD.
Diffuse Cystic Lung Disease. Part II
Gupta, Nishant , Vassallo, Robert , Wikenheiser‐Brokamp, Kathryn A. , McCormack, Francis X. , McCormack, Francis X , Vassallo, Robert , Gupta, Nishant

American Journal of Respiratory and Critical Care Medicine | April 23, 2015 | Volume: 192 | Issue: 1 | Pages: 17-29

10.1164/rccm.201411-2096ci | PMID 25906201 Get It

Abstract The diffuse cystic lung diseases have a broad differential diagnosis. A wide variety of pathophysiological processes spanning the spectrum from airway obstruction to lung remodeling can lead to multifocal cyst development in the lung. Although lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis are perhaps more frequently seen in the clinic, disorders such as Birt-Hogg-Dubé syndrome, lymphocytic interstitial pneumonia, follicular bronchiolitis, and light-chain deposition disease are increasingly being recognized. Obtaining an accurate diagnosis can be challenging, and management approaches are highly disease dependent. Unique imaging features, genetic tests, serum studies, and clinical features provide invaluable clues that help clinicians distinguish among the various etiologies, but biopsy is often required for definitive diagnosis. In part II of this review, we present an overview of the diffuse cystic lung diseases caused by lymphoproliferative disorders, genetic mutations, or aberrant lung development and provide an approach to aid in their diagnosis and management.
Diffuse Cystic Lung Disease. Part I
Gupta, Nishant , Vassallo, Robert , Wikenheiser‐Brokamp, Kathryn A. , McCormack, Francis X. , McCormack, Francis X , Vassallo, Robert , Gupta, Nishant

American Journal of Respiratory and Critical Care Medicine | April 23, 2015 | Volume: 191 | Issue: 12 | Pages: 1354-1366

10.1164/rccm.201411-2094ci | PMID 25906089 Get It

Abstract The diffuse cystic lung diseases (DCLDs) are a group of pathophysiologically heterogenous processes that are characterized by the presence of multiple spherical or irregularly shaped, thin-walled, air-filled spaces within the pulmonary parenchyma. Although the mechanisms of cyst formation remain incompletely defined for all DCLDs, in most cases lung remodeling associated with inflammatory or infiltrative processes results in displacement, destruction, or replacement of alveolar septa, distal airways, and small vessels within the secondary lobules of the lung. The DCLDs can be broadly classified according to underlying etiology as those caused by low-grade or high-grade metastasizing neoplasms, polyclonal or monoclonal lymphoproliferative disorders, infections, interstitial lung diseases, smoking, and congenital or developmental defects. In the first of a two-part series, we present an overview of the cystic lung diseases caused by neoplasms, infections, smoking-related diseases, and interstitial lung diseases, with a focus on lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.
Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014
Fromm, Jonathan R. , Tagliente, Damian J., Shaver, Aaron C., Neppalli, Vishala T., Craig, Fiona E.

Cytometry Part B: Clinical Cytometry | April 23, 2015 | Volume: 88 | Issue: 6 | Pages: 413-424

10.1002/cyto.b.21238 | PMID 25906760 Get It

The Case Study Interpretation (CSI) cases presented at the 2014 International Clinical Cytometry Society (ICCS) meeting in Seattle illustrate the utility of state‐of‐the art multiparameter flow cytometry in the diagnosis of hematolymphoid neoplasms. Download the listmode files (Supporting Information) and test your analysis skills before reading the case reports, keeping in mind the following questions. How many separate abnormal mature B‐cell populations can you identify, and how many of these represent different subtypes of B‐cell neoplasm? How many separate abnormal mature T‐cell populations can you identify, and do these represent different subtypes of T‐cell neoplasm or phenotypic heterogeneity in one neoplasm? How many separate immature/blastic cell populations can you identify, and do they meet criteria for mixed phenotype leukemia? Is there a population of blasts that lacks T‐cell, B‐cell, and myeloid lineage defining antigens and if so, what entities should you consider and what additional antigens should you assess for? © 2015 International Clinical Cytometry Society
Risk Stratification of Diabetics With Stress Testing
Pellikka, Patricia A. , Pellikka, Patricia A

Circulation: Cardiovascular Imaging | April 23, 2015 | Volume: 8 | Issue: 5 | Pages: No page available

10.1161/circimaging.115.003412 | PMID 25904577 Get It

Contributions of Increasing Obesity and Diabetes to Slowing Decline in Subclinical Coronary Artery Disease
Bailey, Kent R. , Emerson, Jane A., Nemetz, Peter N., Roger, Véronique L. , Edwards, William D. , Leibson, Cynthia L., Smith, Carin Y. , Palumbo, Pasquale J

Journal of the American Heart Association | April 23, 2015 | Volume: 4 | Issue: 4 | Pages: No page available

10.1161/jaha.114.001524 | PMID 25904589 Get It

Background Our previous study of nonelderly adult decedents with nonnatural (accident, suicide, or homicide) cause of death (96% autopsy rate) between 1981 and 2004 revealed that the decline in subclinical coronary artery disease ( CAD ) ended in the mid‐1990s. The present study investigated the contributions of trends in obesity and diabetes mellitus to patterns of subclinical CAD and explored whether the end of the decline in CAD persisted. Methods and Results We reviewed provider‐linked medical records for all residents of Olmsted County, Minnesota , who died from nonnatural causes within the age range of 16 to 64 years between 1981 and 2009 and who had CAD graded at autopsy. We estimated trends in CAD risk factors including age, sex, systolic blood pressure, diabetes (qualifying fasting glucose or medication), body mass index, smoking, and diagnosed hyperlipidemia. Using multiple regression, we tested for significant associations between trends in CAD risk factors and CAD grade and assessed the contribution of trends in diabetes and obesity to CAD trends. The 545 autopsied decedents with recorded CAD grade exhibited significant declines between 1981 and 2009 in systolic blood pressure and smoking and significant increases in blood pressure medication, diabetes, and body mass index ≥30 kg/m 2 . An overall decline in CAD grade between 1981 and 2009 was nonlinear and ended in 1994. Trends in obesity and diabetes contributed to the end of CAD decline. Conclusions Despite continued reductions in smoking and blood pressure values, the previously observed end to the decline in subclinical CAD among nonelderly adult decedents was apparent through 2009, corresponding with increasing obesity and diabetes in that population.
Acquired axonal degeneration and regeneration
Benarroch, Eduardo E.

Neurology | April 23, 2015 | Volume: 84 | Issue: 20 | Pages: 2076-2085

10.1212/wnl.0000000000001601 | PMID 25904690 Get It

Enhanced Classification of Brugada Syndrome–Associated and Long-QT Syndrome–Associated Genetic Variants in the SCN5A -Encoded Na v 1.5 Cardiac Sodium Channel
Kapplinger, Jamie D., Giudicessi, John R. , Ye, Dan , Tester, David J. , Callis, Thomas E. , Valdivia, Carmen R. , Makielski, Jonathan C., Wilde, Arthur A.M. , Ackerman, Michael J. , Wilde, Arthur A

Circulation: Cardiovascular Genetics | April 22, 2015 | Volume: 8 | Issue: 4 | Pages: 582-595

10.1161/circgenetics.114.000831 | PMID 25904541 Get It

Background— A 2% to 5% background rate of rare SCN5A nonsynonymous single nucleotide variants (nsSNVs) among healthy individuals confounds clinical genetic testing. Therefore, the purpose of this study was to enhance interpretation of SCN5A nsSNVs for clinical genetic testing using estimated predictive values derived from protein-topology and 7 in silico tools. Methods and Results— Seven in silico tools were used to assign pathogenic/benign status to nsSNVs from 2888 long-QT syndrome cases, 2111 Brugada syndrome cases, and 8975 controls. Estimated predictive values were determined for each tool across the entire SCN5A -encoded Na v 1.5 channel as well as for specific topographical regions. In addition, the in silico tools were assessed for their ability to correlate with cellular electrophysiology studies. In long-QT syndrome, transmembrane segments S3–S5+S6 and the DIII/DIV linker region were associated with high probability of pathogenicity. For Brugada syndrome, only the transmembrane spanning domains had a high probability of pathogenicity. Although individual tools distinguished case- and control-derived SCN5A nsSNVs, the composite use of multiple tools resulted in the greatest enhancement of interpretation. The use of the composite score allowed for enhanced interpretation for nsSNVs outside of the topological regions that intrinsically had a high probability of pathogenicity, as well as within the transmembrane spanning domains for Brugada syndrome nsSNVs. Conclusions— We have used a large case/control study to identify regions of Na v 1.5 associated with a high probability of pathogenicity. Although topology alone would leave the variants outside these identified regions in genetic purgatory, the synergistic use of multiple in silico tools may help promote or demote a variant’s pathogenic status.
From bench to bedside: utility of the rabbit elastase aneurysm model in preclinical studies of intracranial aneurysm treatment
Brinjikji, Waleed , Ding, Yong Hong, Kallmes, David F. , Kadirvel, Ramanathan , Ding, Yong H, Ding, Yonghong

Journal of NeuroInterventional Surgery | April 22, 2015 | Volume: 8 | Issue: 5 | Pages: 521-525

10.1136/neurintsurg-2015-011704 | PMID 25904642 Get It

Preclinical studies are important in helping practitioners and device developers improve techniques and tools for endovascular treatment of intracranial aneurysms. Thus an understanding of the major animal models used in such studies is important. The New Zealand rabbit elastase induced arterial aneurysm of the common carotid artery is one of the most commonly used models in testing the safety and efficacy of new endovascular devices. In this review we discuss: (1) the various techniques used to create the aneurysm, (2) complications of aneurysm creation, (3) natural history of the arterial aneurysm, (4) histopathologic and hemodynamic features of the aneurysm, (5) devices tested using this model, and (6) weaknesses of the model. We demonstrate how preclinical studies using this model are applied in the treatment of intracranial aneurysms in humans. The model has similar hemodynamic, morphological, and histologic characteristics to human aneurysms, and demonstrates similar healing responses to coiling as human aneurysms. Despite these strengths, however, the model does have many weaknesses, including the fact that the model does not emulate the complex inflammatory processes affecting growing and ruptured aneurysms. Furthermore, the extracranial location of the model affects its ability to be used in preclinical safety assessments of new devices. We conclude that the rabbit elastase model has characteristics that make it a simple and effective model for preclinical studies on the endovascular treatment of intracranial aneurysms, but further work is needed to develop aneurysm models that simulate the histopathologic and morphologic characteristics of growing and ruptured aneurysms.